Raymond James Downgrades Liquidia to Outperform, Lowers Price Target to $53

10/1/2026
Impact: -70
Healthcare

Raymond James analyst Ryan Deschner has downgraded Liquidia (NASDAQ: LQDA) from a Strong Buy rating to Outperform. Additionally, the price target for the stock has been reduced from $106 to $53.

AI summary, not financial advice

Share: